LU54664A1 - - Google Patents

Info

Publication number
LU54664A1
LU54664A1 LU54664DA LU54664A1 LU 54664 A1 LU54664 A1 LU 54664A1 LU 54664D A LU54664D A LU 54664DA LU 54664 A1 LU54664 A1 LU 54664A1
Authority
LU
Luxembourg
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10444820&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU54664(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of LU54664A1 publication Critical patent/LU54664A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/20—Rubella virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
LU54664D 1966-10-21 1967-10-12 LU54664A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB47399/66A GB1135987A (en) 1966-10-21 1966-10-21 Attenuated live rubella virus vaccine and method of production

Publications (1)

Publication Number Publication Date
LU54664A1 true LU54664A1 (en) 1967-12-12

Family

ID=10444820

Family Applications (1)

Application Number Title Priority Date Filing Date
LU54664D LU54664A1 (en) 1966-10-21 1967-10-12

Country Status (19)

Country Link
US (1) US3686394A (en)
AT (1) AT279038B (en)
BE (1) BE705342A (en)
BR (1) BR6794003D0 (en)
CA (1) CA956232A (en)
CH (1) CH477553A (en)
CY (1) CY635A (en)
DE (1) DE1617775B1 (en)
DK (1) DK121619B (en)
ES (1) ES345972A1 (en)
FI (1) FI43625B (en)
FR (2) FR1548489A (en)
GB (1) GB1135987A (en)
IL (1) IL28696A (en)
LU (1) LU54664A1 (en)
NL (1) NL148799B (en)
NO (1) NO125776B (en)
SE (1) SE341451B (en)
YU (1) YU31804B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2129777C3 (en) * 1971-06-16 1982-04-15 Takeda Chemical Industries, Ltd., Osaka Process for the preparation of a severely weakened rubella virus vaccine
FR2505657A1 (en) * 1981-05-13 1982-11-19 Pasteur Institut IMPROVEMENTS IN LIVE STABILIZING AGENTS FOR THE PREPARATION OF VACCINES, AND STABILIZED VACCINES CONTAINING SAID STABILIZING AGENTS
US8460680B2 (en) * 2009-04-24 2013-06-11 National Health Research Institutes Polyvalent chimeric rubella virus-based vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3401084A (en) * 1965-07-29 1968-09-10 Merck & Co Inc Rubella vaccine and its preparation

Also Published As

Publication number Publication date
CH477553A (en) 1969-08-31
CY635A (en) 1972-03-07
AT279038B (en) 1970-02-25
YU203467A (en) 1973-06-30
US3686394A (en) 1972-08-22
IL28696A (en) 1971-12-29
DK121619B (en) 1971-11-08
BR6794003D0 (en) 1973-02-22
YU31804B (en) 1973-12-31
BE705342A (en) 1968-03-01
GB1135987A (en) 1968-12-11
NO125776B (en) 1972-10-30
NL148799B (en) 1976-03-15
ES345972A1 (en) 1968-12-01
FR1548489A (en) 1968-12-06
FI43625B (en) 1971-02-01
NL6714223A (en) 1968-04-22
DE1617775B1 (en) 1970-10-22
CA956232A (en) 1974-10-15
FR7321M (en) 1969-10-06
SE341451B (en) 1971-12-27

Similar Documents

Publication Publication Date Title
AT281852B (en)
FI43625B (en)
AU424443B2 (en)
AU1534566A (en)
AU218666A (en)
AU1393566A (en)
AU1144366A (en)
AU1111066A (en)
BE677615A (en)
BE674713A (en)
BE692932A (en)
BE692549A (en)
BE692014A (en)
BE689982A (en)
BE689769A (en)
BE685868A (en)
BE685295A (en)
BE682907A (en)
BE693098A (en)
BE675139A (en)
BE674987A (en)
BE674792A (en)
BE674777A (en)
BE693083A (en)
BE673316A (en)